相关实验视频
Updated: Jan 16, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
906
非粉蔬菜消费对超重和肥胖大学人口体重状况的影响
Urwah Ashraf1, Qaisar Raza1, Minahil Safdar1
1Department of Food Science and Human Nutrition, University of Veterinary and Animal Sciences, Lahore, PAK.
Cureus
|September 29, 2025
概括
在超重和肥胖个体中,每天摄入非粉蔬菜显著降低了身体脂肪百分比和内脏脂肪. 这种饮食干预为风险人群的体重管理和改善身体组成提供了有希望的策略.
科学领域:
- 营养科学 营养科学
- 公共卫生 公共卫生
- 人体生理学 人体生理学
背景情况:
- 肥胖是一个全球性的健康问题,与II型糖尿病 (T2DM),心血管疾病 (CVD) 和癌症有关.
- 水果和蔬菜可以提供对非传染性疾病的保护.
- 关于非粉蔬菜对体重和人类参数的影响的数据有限.
研究的目的:
- 为了研究每日推的非粉蔬菜摄入量对体重状况的影响.
- 评估身体质量指数 (BMI) 的变化,脂肪质量 (人体脂肪百分比 (PBF),内脏脂肪 (VF) 和腰部至部比 (WHR).
- 在超重和肥胖的大学人口中评估这些影响.
主要方法:
- 试验性随机对照试验 (RCT) 与40名超重/肥胖参与者 (BMI ≥23kg/m2) 进行.
- 干预组:每天2-3杯 (250g) 不含粉的蔬菜.
- 控制组:接受了一般的饮食建议.
- 测量:体重,BMI,PBF,VF,WHR在干预前和后使用Inbody270.0进行评估.
主要成果:
- 干预组显示PBF (p=0.029) 和VF (p<0.001) 的显著减少.
- 对照组体重,BMI,PBF和VF没有显著变化.
- 与对照组相比,干预组的基线PBF和VF显著更高.
结论:
- 每天摄入非粉蔬菜导致体重,BMI,PBF,VF和WHR的微妙改善.
- 干预组在人体组成参数方面表现出显著的改善.
- 专注于非粉蔬菜的饮食干预措施可能对控制体重和改善肥胖人口的健康标志物有好处.
相关概念视频
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Regulation of Food Intake
2.3K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
247
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
247
Assessment of the Gastrointestinal System II: Health Perception Pattern
455
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
455
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169

